Gary Tyson is an expert on clinical operations with over 30 years of experience consulting to the biopharma and CROs industry. Gary has helped clients successfully execute a range of “non-standard” studies, including Exception From Informed Consent, Virtual Clinical Trials and High Risk Studies. Gary formed Pharma Initiatives in 2014. Gary, his partner Mark Shapiro and staff at Pharma Initiatives view their role as trusted advisor, driver and supporter of successful study execution for the most challenging clinical studies.